THE INCIDENCE AND CLINICAL IMPLICATIONS OF CHROMOTHRIPSIS IN BONE MARROW CELLS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
|
作者：
Zemanova, Z. [1 ,2 ]
Michalova, K. [1 ,2 ,3 ]
Brezinova, J. [3 ]
Lhotska, H. [1 ,2 ]
Svobodova, K. [1 ,2 ]
Sarova, I. [1 ,2 ,3 ]
Lizcova, L. [1 ,2 ]
Izakova, S. [1 ,2 ]
Ransdorfova, S. [3 ]
Zdenek, K. [3 ]
Belickova, M. [3 ]
Jonasova, A. [2 ,4 ]
Siskova, M. [2 ,4 ]
Neuwirtova, R. [2 ,4 ]
Cermak, J. [3 ]
机构：
[1] Charles Univ Prague, Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Ctr Oncocytogenet, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Charles Univ Prague, Gen Univ Hosp, Inst Hematol & Blood Transfus, Prague, Czech Republic
[4] Charles Univ Prague, Med Dept 1, Gen Univ Hosp, Prague, Czech Republic
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P246
引用
收藏
页码：69 / 70
页数：2
相关论文
共 50 条
  • [1] CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES.
    Zemanova, Z.
    Lhotska, H.
    Brezinova, J.
    Lizcova, L.
    Svobodova, K.
    Sarova, I.
    Izakova, S.
    Ransdorfova, S.
    Krejcik, Z.
    Dostalova, M.
    Siskova, M.
    Jonasova, A.
    Neuwirtova, R.
    Cermak, J.
    Michalova, K.
    [J]. HAEMATOLOGICA, 2014, 99 : 82 - 82
  • [2] COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Lizcova, L.
    Izakova, S.
    Bystricka, D.
    Sarova, I.
    Siskova, M.
    Neuwirtova, R.
    Cerna, O.
    Cermak, J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 13 - 14
  • [3] Dynamics of the apoptotic death of bone marrow cells in myelodysplastic syndromes (MDS).
    Mundle, S
    Cartlidge, J
    Venugopal, P
    Gezer, S
    Hines, C
    Jassak, P
    Gregory, SA
    Alvi, S
    Shetty, V
    Robin, E
    Kawauchi, R
    Rifkin, S
    Alston, D
    Hernandez, B
    Shah, R
    Raza, A
    [J]. EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 309 - 309
  • [4] The clinical significance or apoptosis in the marrow of patients with primary myelodysplastic syndromes (MDS)
    Kouraklis, A
    Tsoplou, P
    Symeonidis, A
    Orphanos, V
    Zoumbos, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 263 - 263
  • [5] Bone marrow transplantation (BMT) in children with myelodysplastic syndromes (MDS).
    Hoogerbrugge, PM
    Rossum, M
    Vries, E
    Gerritsen, EJA
    Weel, M
    Veer, ET
    Vossen, JMJJ
    [J]. BLOOD, 1995, 86 (10) : 353 - 353
  • [6] The myelodysplastic syndromes (MDS): Is bone marrow examination always necessary?
    Carmi, G.
    Oster, H. S.
    Kolomansky, A.
    Kyrzner, I.
    Naparstek, E.
    Comaneshter, D.
    Mittelman, M.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S117 - S117
  • [7] Prognostic impact of bone marrow fibrosis in myelodysplastic syndromes (MDS)
    Baghikar, S.
    Braunstein, S.
    Reinecke, P.
    Knipp, S.
    Haas, R.
    Hildebrandt, B.
    Gattermann, N.
    Germing, U.
    Schmidt-Graef, A.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S100 - S100
  • [8] Involvement of bone marrow stroma in pathogenesis of myelodysplastic syndromes (MDS).
    Alvi, S
    Henderson, B
    Flores-Figueroa, E
    Zorat, F
    Shaher, A
    Mansoob, F
    Broderick, E
    Patel, S
    Khan, I
    Borok, RZ
    Raza, A
    [J]. BLOOD, 1999, 94 (10) : 161B - 161B
  • [9] Allogeneic bone marrow transplantation (alloBMT) in myelodysplastic syndromes (MDS).
    Karanes, C
    Abella, E
    Du, W
    Klein, J
    Dansey, R
    Cassells, L
    Peters, W
    Baynes, R
    [J]. BLOOD, 1998, 92 (10) : 659A - 659A
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    ARNOLD, R
    HEIMPEL, H
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 101 - 103
12345